Early response of neurons and glial cells to hypoxia in the retina

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 3, 2006, Pages 1125-1141

  Kaur, Charanjit ^a   Sivakumar, Viswanathan ^a   Foulds, Wallace S ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 3; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROTEIN COMPLEMENT TYPE 3 RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; AMPA RECEPTOR; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 2; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 3; HIF1A PROTEIN, RAT; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NMDA RECEPTOR A1; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXCITOTOXICITY; GENE EXPRESSION; GLIA CELL; HYPOXIA; IMMUNOHISTOCHEMISTRY; MICROGLIA; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA; RETINA HEMORRHAGE; RETINOPATHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANOXIA; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; GLIA; METABOLISM; RETINA DISEASE;

ANIMALS; ANOXIA; BLOTTING, WESTERN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEUROGLIA; NEURONS; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE; RETINAL DISEASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645403672     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0518     Document Type: Article

References (66)

1. Ottino P, Finley J, Rojo E, et al. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: involvement of cytosolic phospholipase A2 activity. Mol Vis. 2004;10:341-350.
2. Michaelson IC. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK. 1948;68:137-180.
3. Patz A. Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture. Am J Ophthalmol. 1982;94:715-743.
4. Ditzel J. Affinity hypoxia as a pathogenetic factor of microangiopathy with particular reference to diabetic retinopathy. Acta Endocrinol Suppl (Copenh). 1980;238:39-55.
5. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest. 1995;72:638-645.
6. Marsh S, Nakhoul FM, Skorecki K, et al. Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy. Diabetes Care. 2000;23:1375-1380.
7. Nguyen QD, Shah SM, Van Anden E, Sung JU, Vitale S, Campochiaro PA. Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci. 2004;45:617-624.
8. Nyengaard JR, Ido Y, Kilo C, Williamson JR. Interactions between hyperglycemia and hypoxia: implications for diabetic retinopathy. Diabetes. 2004;53:2931-2938.
9. Malik RA, Li C, Aziz W, et al. Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. J Cell Mol Med. 2005;9:692-697.
10. Brown GC, Magargal LE. The ocular ischemic syndrome: clinical, fluorescein andiographic, and carotid angiographic features. Int Ophthalmol. 1988;11:239-251.
11. Shelhamer JH, Volkman DJ, Parrillo JE, et al. Takayasu's arteritis and its therapy. Ann Intern Med. 1985;103:121-126.
12. Ashton N, Foulds WS. Ocular pathology in macroglobulinaemia. J Pathol Bact. 1963;86:453-461.
13. Purtscher O. Angiopathia retinae traumatica: lymphorrhagien des augengrundes. Graefes Arch Klin Exp Ophthalmol. 1912;82:347-371.
14. Buckley SA, James B. Purtscher's retinopathy. Postgrad Med J. 1996;72:409-412.
15. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 1991;14:60-67.
16. Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res. 1999;31:577-596.
17. Black SM, Bedolli MA, Martinez S, Bristow JD, Ferriero DM, Soifer SJ. Expression of neuronal nitric oxide synthase corresponds to regions of selective vulnerability to hypoxia-ischaemia in the developing rat brain. Neurobiol Dis. 1995;2:145-155.
18. Adachi K, Kashii S, Masai H, et al. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch Clin Exp Ophthalmol. 1998;236:766-774.
19. Saxon DW, Beitz AJ. Induction of NADPH-diaphorase/nitric oxide synthase in the brainstem trigeminal system resulting from cerebellar lesions. J Comp Neurol. 1996;371:41-71.
20. Chen S, Aston-Jones G. Cerebellar injury induces NADPH diaphorase in Purkinje and inferior olivary neurons in the rat. Exp Neurol. 1994;126:270-276.
21. Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol. 1986;19:105-111.
22. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1988;1:623-634.
23. Nicholls D, Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol Sci. 1990;11:462-468.
24. Barenberg P, Strahlendorf H, Strahlendorf J. Hypoxia induces an excitotoxic-type of dark cell degeneration in cerebellar Purkinje neurons. Neurosci Res. 2001;40:245-254.
25. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 1997;37:3483-3493.
26. Joo CK, Choi JS, Ko HW, et al. Necrosis and apoptosis after retinal ischemia: involvement of NMDA-mediated excitotoxicity and p53. Invest Ophthalmol Vis Sci. 1999;40:713-720.
27. Kiss JP, Vizi ES. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci. 2001;24:211-215.
28. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992;359:845-848.
29. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843-845.
30. Grimm C, Wenzel A, Groszer M, et al. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med. 2002;8:718-724.
31. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells identification of a 5′ enhancer. Circ Res. 1995;77:638-643.
32. Schuetz E, Thanos S. Microglia-targeted pharmacotherapy in retinal neurodegenerative diseases. Curr Drug Targets. 2004;5:619-627.
33. Kaur C, Ling EA. Activation and re-expression of surface antigen in microglia following an epidural application of kainic acid in the rat brain. J Anat. 1992;180:333-342.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T) method. Methods. 2001;24:402-408.
35. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
36. McColm JR, Geisen P, Hartnett ME. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol Vis. 2004;10:512-520.
37. Sattler R, Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol. 2001;24:107-129.
38. Frandsen A, Schousboe A. AMPA receptor-mediated neurotoxicity: role of Ca2+ and desensitization. Neurochem Res. 2003;28:1495-1499.
39. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci. 2001;69:369-381.
40. Facci L, Leon A, Skaper SD. Excitatory amino acid neurotoxicity in cultured retinal neurons: involvement of N-methyl-D-aspartate (NMDA) and non-NMDA receptors and effect of ganglioside GM1. J Neurosci Res. 1990;27:202-210.
41. Rembach A, Turner BJ, Bruce S, et al. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS. J Neurosci Res. 2004;77:573-582.
42. Thoreson WB, Witkovsky P. Glutamate receptors and circuits in the vertebrate retina. Prog Retin Eye Res. 1999;18:765-810.
43. Dawson VL, Dawson TM. Nitric oxide neurotoxicity. J Chem Neuroanat. 1996;10:179-190.
44. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 1997;20:132-139.
45. Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase in models of focal ischemia. Stroke. 1997;28:1283-1288.
46. Zhang ZG, Chopp M, Gautam S, et al. Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res. 1994;654:85-95.
47. Guo Y, Ward ME, Beasjours S, Mori M, Hussain SN. Regulation of cerebellar nitric oxide production in response to prolonged in vivo hypoxia. J Neurosci Res. 1997;49:89-97.
48. Moro MA, De Alba J, Leza JC, et al. Neuronal expression of inducible nitric oxide synthase after oxygen and glucose deprivation in rat forebrain slices. Eur J Neurosci. 1998;10:445-456.
49. Li RC, Row BW, Kheirandish L, et al. Nitric oxide synthase and intermittent hypoxia-induced spatial learning deficits in the rat. Neurobiol Dis. 2004;17:44-53.
50. Nagaoka T, Sakamoto T, Mori F, Sato E, Yoshida A. The effect of nitric oxide on retinal blood flow during hypoxia in cats. Invest Ophthalmol Vis Sci. 2002;43:3037-3044.
51. Yousef T, Neubacher U, Eysel UT, Volgushev M. Nitric oxide synthase in rat visual cortex: an immunohistochemical study. Brain Res Brain Res Protoc. 2004;13:57-67.
52. Yamamoto Y, Henrich M, Snipes RL, Kummer W. Altered production of nitric oxide and reactive oxygen species in rat nodose ganglion neurons during acute hypoxia. Brain Res. 2003;961:1-9.
53. Hashiguchi A, Yano S, Morioka M, et al. Up-regulation of endothelial nitric oxide synthase via phosphatidylinositol 3-kinase pathway contributes to ischemic tolerance in the CA1 subfield of gerbil hippocampus. J Cereb Blood Flow Metab. 2004;24:271-279.
54. Jadwiga Joœko, Micha ł Mazurek. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit. 2004;10:RA89-RA98.
55. Fukumura D, Gohongi T, Kadambi A, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA. 2001;98:2604-2609.
56. Sennlaub F, Courtois Y, Goureau O. Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy. J Clin Invest. 2001;107:717-725.
57. Schoch HJ, Fischer S, Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain. 2002;125:2549-2557.
58. Ozaki H, Yu AY, Della N, et al. Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci. 1999;40:182-189.
59. Rosenstein JM, Krum JM. New roles for VEGF in nervous tissue: beyond blood vessels. Exp Neurol. 2004;187:246-253.
60. Josko J, Hendryk S, J'drzejowska-Szypulka H, et al. Effect of phosphoramidon on brain tissue angiogenesis in the chronic phase of vasospasm after subarachnoid hemorrhage in the rat. Med Sci Monit. 2001;7:1182-1187.
61. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA. 2002;99:11946-11950.
62. Wakakura M, Foulds WS. Response of cultured Müller cells to heat shock: an immunocytochemical study of heat shock and intermediate filament proteins in response to temperature elevation. Exp Eye Res. 1989;48:337-350.
63. Lupien C, Brenner M, Guerin SL, Salesse C. Expression of glial fibrillary acidic protein in primary cultures of human Müller cells. Exp Eye Res. 2004;79:423-429.
64. Degrossoli A, Colhone MC, Arrais-Silva WW, Giorgio S. Hypoxia modulates expression of the 70-kD heat shock protein and reduces Leishmania infection in macrophages. J Biomed Sci. 2004;11:847-854.
65. Kaur C, Singh J, Peng CM, Ling EA. Upregulation of adrenocorticotrophic hormone in the corticotrophs and downregulation of surface receptors and antigens on the macrophages in the adenohypophysis following an exposure to high altitude. Neurosci Lett. 2002;318:125-128.
66. Graeber MB, Streit WJ, Kreutzberg GW. Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells. J Neurosci Res. 1988;21:18-24.